Combined antihypertensive therapy: vasodilatation using prazosin in combination with beta-adrenoceptor blockers and diuretics

References

• Gabriel R., Meek D., Mamtora H. Collapse after prazosin hydrochloride. Lancet 1975; 1: 10951. Gabriel R., Meek D., Mamtora H. Collapse after prazosin hydrochloride. Lancet 1975; 1: 1095
   PubMed Web of Science ®Google Scholar
• Hansson L., Hunyor S. N. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med. Scand. 1974; 196: 27–342. Hansson L., Hunyor S. N. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med. Scand. 1974; 196: 27–34
   PubMed Web of Science ®Google Scholar
• Hansson L., Werko L. Beta-adrenergic blockade in hypertension. Am. Heart J. 1977; 93: 394–4023. Hansson L., Werko L. Beta-adrenergic blockade in hypertension. Am. Heart J. 1977; 93: 394–402
   PubMed Web of Science ®Google Scholar
• Hayes J. M., Graham R. M., O'Connell B. P. Experience with prazosin in the treatment of patients with severe hypertension. Med. J. Aust. 1976; 1: 562–5644. Hayes J. M., Graham R. M., O'Connell B. P. Experience with prazosin in the treatment of patients with severe hypertension. Med. J. Aust. 1976; 1: 562–564
   PubMed Web of Science ®Google Scholar
• Hayes J. M., Graham R. M., O'Connell B. P., Speers E., Humphrey T. J. Effect of prazosin on plasma renin activity. Aust. N.Z. J. Med. 1976; 6: 82–1025. Hayes J. M., Graham R. M., O'Connell B. P., Speers E., Humphrey T. J. Effect of prazosin on plasma renin activity. Aust. N.Z. J. Med. 1976; 6: 82–102
   Google Scholar
• Ibsen K., Rasmussen K., Aerenlund H. Changes in plasma volume, extracellular volume and glomerular filtration rate during combined antihypertensive treatment with propranolol and prazosin. Curr. Med. Res. Opin. 1976; 4: 83–88, Suppl. 26. Ibsen K., Rasmussen K., Aerenlund H. Changes in plasma volume, extracellular volume and glomerular filtration rate during combined antihypertensive treatment with propranolol and prazosin. Curr. Med. Res. Opin. 1976; 4: 83–88, Suppl. 2
   Web of Science ®Google Scholar
• Kinaid-Smith P., Fang P., Laver M. C. A new look at the treatment of severe hypertension. Clin. Sci. Mol. Med. 1973; 45: 75–877. Kinaid-Smith P., Fang P., Laver M. C. A new look at the treatment of severe hypertension. Clin. Sci. Mol. Med. 1973; 45: 75–87
   Google Scholar
• Morgan T. O., Sabro J., Anavekar S. N., Louis W. J., Doyle A. E. A comparison of beta-adrenergic blocking drugs in the treatment of hypertension. Posrgrad. Med. J. 1974; 50: 253–2598. Morgan T. O., Sabro J., Anavekar S. N., Louis W. J., Doyle A. E. A comparison of beta-adrenergic blocking drugs in the treatment of hypertension. Posrgrad. Med. J. 1974; 50: 253–259
   Web of Science ®Google Scholar
• Mroczek W. J., Lee W. R., Davidov M. E., Finnerty F. A. Vasodilator administration in the presence of beta-adrenergic blockade. Circulation 1976; 53: 985–9889. Mroczek W. J., Lee W. R., Davidov M. E., Finnerty F. A. Vasodilator administration in the presence of beta-adrenergic blockade. Circulation 1976; 53: 985–988
   PubMed Web of Science ®Google Scholar
• Pitts N. E. The clinical evaluation of prazosin hydrochloride, a new anti-hypertensive agent. Prazosin - Evaluation of a New Antihypertensive Agent, D. W. Cotton. K.I.C.S. No. 331, Excerpta Media, Geneva 1974; 9210. Pitts N. E. The clinical evaluation of prazosin hydrochloride, a new anti-hypertensive agent. Prazosin - Evaluation of a New Antihypertensive Agent, D. W. Cotton. K.I.C.S. No. 331, Excerpta Media, Geneva 1974; 92
   Google Scholar
• Seedat Y. K., Bhoola R., Rampons J. G. Prazosin in the treatment of hypertension. Br. Med J. 1975; 3: 30511. Seedat Y. K., Bhoola R., Rampons J. G. Prazosin in the treatment of hypertension. Br. Med J. 1975; 3: 305
   PubMed Web of Science ®Google Scholar
• Stokes G. S., Gain J. M., Mahony J. F., Raftos J., Stewart J. H. Long-term use of prazosin in combination or alone for treating hypertension. Med. J. Aust. 1977; 2: 13–16, Suppl.12. Stokes G. S., Gain J. M., Mahony J. F., Raftos J., Stewart J. H. Long-term use of prazosin in combination or alone for treating hypertension. Med. J. Aust. 1977; 2: 13–16, Suppl.
   PubMed Web of Science ®Google Scholar
• Tarazi R. C., Dustan H. P. Beta-adrenergic blockade in hypertension: practical and theoretical implications of long-term hemodynamic variations. Am J. Cardiol. 1972; 29: 633–64013. Tarazi R. C., Dustan H. P. Beta-adrenergic blockade in hypertension: practical and theoretical implications of long-term hemodynamic variations. Am J. Cardiol. 1972; 29: 633–640
   PubMed Web of Science ®Google Scholar
• World Health Organization. Arterial Hypertension. Report of a WHO Expert Committee. Technical Reports Series, WHO, Geneva 1978; 628: 9–1014. World Health Organization. Arterial Hypertension. Report of a WHO Expert Committee. Technical Reports Series, WHO, Geneva 1978; 628: 9–10
   Google Scholar
• Wibell L. B., Berne C., Waern A. U., Lithell H. Prazosin influence on carbohydrate and lipoprotein metabolism. Proc. R. Soc. Med 1980, Accepted for publication15. Wibell L. B., Berne C., Waern A. U., Lithell H. Prazosin influence on carbohydrate and lipoprotein metabolism. Proc. R. Soc. Med 1980, Accepted for publication
   Google Scholar
• Zacest R., Gilmore E., Koch-Weser J. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. N. Engl. J. Med. 1972; 286: 617–62216. Zacest R., Gilmore E., Koch-Weser J. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. N. Engl. J. Med. 1972; 286: 617–622
   PubMed Web of Science ®Google Scholar
• Zacharias F. J., Cowen K. J., Rest J., Vickers J., Wall B. G. Propranolol in hypertension: a study of long-term therapy, 1964–1970. Am. Heart J. 1972; 83: 755–76117. Zacharias F. J., Cowen K. J., Rest J., Vickers J., Wall B. G. Propranolol in hypertension: a study of long-term therapy, 1964–1970. Am. Heart J. 1972; 83: 755–761
   PubMed Web of Science ®Google Scholar